Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F13FW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,213
Award facts
- Contract value 100% obligated
- $7,212.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Xifaxan 550 mg tablets (60 count) with a ceiling value of $7,212.70. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of drug deliveries to the Defense Logistics Agency and related military healthcare systems. The company consistently secures competitive federal awards for pharmaceutical products spanning multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for Xifaxan—an antibiotic medication—exemplifies AmerisourceBergen's role as a critical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F13FW?
SPE2DR26F13FW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F13FW worth?
The government has obligated $7,213 on SPE2DR26F13FW.
Is contract SPE2DR26F13FW an order under another contract?
Yes. SPE2DR26F13FW is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13FW competed?
The extent of competition for SPE2DR26F13FW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award